Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.

Liu C, Du H, Wang C, Belinson JL, Yang B, Zhang W, Tang J, Wu R.

Int J Gynecol Pathol. 2017 Mar 8. doi: 10.1097/PGP.0000000000000326. [Epub ahead of print]

PMID:
28277314
2.

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.

Luo H, Belinson JL, Du H, Liu Z, Zhang L, Wang C, Qu X, Pretorius RG, Wu R.

J Low Genit Tract Dis. 2017 Jan;21(1):12-16. doi: 10.1097/LGT.0000000000000277.

PMID:
27851695
3.

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

Arbyn M, Xu L, Verdoodt F, Cuzick J, Szarewski A, Belinson JL, Wentzensen N, Gage JC, Khan MJ.

Ann Intern Med. 2017 Jan 17;166(2):118-127. doi: 10.7326/M15-2735.

PMID:
27842420
4.

A Standard Protocol for the Colposcopy Exam.

Belinson JL, Pretorius RG.

J Low Genit Tract Dis. 2016 Oct;20(4):e61-2. doi: 10.1097/LGT.0000000000000239. No abstract available.

PMID:
27428609
5.

High-Grade Cervical Intraepithelial Neoplasia Detected by Colposcopy-Directed or Random Biopsy Relative to Age, Cytology, Human Papillomavirus 16, and Lesion Size.

Chen Q, Du H, Pretorius RG, Wang C, Yang B, Wang G, Tang J, Belinson JL, Wu R.

J Low Genit Tract Dis. 2016 Jul;20(3):207-12. doi: 10.1097/LGT.0000000000000184.

PMID:
26855144
6.

p16 Immunohistochemistry in Colposcope-Directed and Random Cervical Biopsies of CIN2 and CIN3.

Arvizo C, Chen Q, Du H, Wang C, Tang J, Yang B, Pretorius RG, Wu R, Belinson JL.

J Low Genit Tract Dis. 2016 Jul;20(3):197-200. doi: 10.1097/LGT.0000000000000181.

PMID:
26855142
7.

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media.

Luo H, Du H, Maurer K, Belinson JL, Wang G, Liu Z, Zhang L, Zhou Y, Wang C, Tang J, Qu X, Wu R.

PLoS One. 2016 Feb 1;11(2):e0148168. doi: 10.1371/journal.pone.0148168.

8.

When Should Endocervical Curettage Be Done?

Pretorius RG, Belinson JL.

J Low Genit Tract Dis. 2016 Apr;20(2):189. doi: 10.1097/LGT.0000000000000180. No abstract available.

PMID:
26796662
9.

Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study.

Levinson KL, Jernigan AM, Flocke SA, Tergas AI, Gunderson CC, Huh WK, Wilkinson-Ryan I, Lawson PJ, Fader AN, Belinson JL.

J Low Genit Tract Dis. 2016 Jan;20(1):47-51. doi: 10.1097/LGT.0000000000000153.

10.

Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.

Zhao J, Du H, Belinson JL, Qu X, Zhang W, Mei J, Yang B, Wang C, Zhang L, Wu R.

J Med Screen. 2016 Mar;23(1):38-43. doi: 10.1177/0969141315604863.

PMID:
26466824
11.

Recommendations for screening and early detection of common cancers in India.

Rajaraman P, Anderson BO, Basu P, Belinson JL, Cruz AD, Dhillon PK, Gupta P, Jawahar TS, Joshi N, Kailash U, Kapambwe S, Katoch VM, Krishnan S, Panda D, Sankaranarayanan R, Selvam JM, Shah KV, Shastri S, Shridhar K, Siddiqi M, Sivaram S, Seth T, Srivastava A, Trimble E, Mehrotra R.

Lancet Oncol. 2015 Jul;16(7):e352-61. doi: 10.1016/S1470-2045(15)00078-9. Review.

PMID:
26149887
12.

Which Colposcopies Should Include Endocervical Curettage?

Pretorius RG, Belinson JL, Peterson P, Burchette RJ.

J Low Genit Tract Dis. 2015 Oct;19(4):278-81. doi: 10.1097/LGT.0000000000000119.

PMID:
26083335
13.

Factors That Virtually Exclude Cervical Cancer at Colposcopy.

Pretorius RG, Belinson JL, Peterson P, Burchette RJ.

J Low Genit Tract Dis. 2015 Oct;19(4):319-22. doi: 10.1097/LGT.0000000000000122.

PMID:
26083334
14.

[Diagnostic value of multiply biopsies and endocervical curettage on cervical lesions].

Zhang L, Du H, Zhang W, Yang B, Wang C, Belinson JL, Wu R.

Zhonghua Fu Chan Ke Za Zhi. 2015 Apr;50(4):263-7. Chinese.

PMID:
26080937
15.

Using implementation science to advance cancer prevention in India.

Krishnan S, Sivaram S, Anderson BO, Basu P, Belinson JL, Bhatla N, D'Cruz A, Dhillon PK, Gupta PC, Joshi N, Jhulka PK, Kailash U, Kapambwe S, Katoch VM, Kaur P, Kaur T, Mathur P, Prakash A, Sankaranarayanan R, Selvam JM, Seth T, Shah KV, Shastri S, Siddiqi M, Srivastava A, Trimble E, Rajaraman P, Mehrotra R.

Asian Pac J Cancer Prev. 2015;16(9):3639-44. Review.

16.

Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off.

Boers A, Slagter-Menkema L, van Hemel BM, Belinson JL, Ruitenbeek T, Buikema HJ, Klip H, Ghyssaert H, van der Zee AG, de Bock GH, Wisman GB, Schuuring E.

PLoS One. 2014 Jul 22;9(7):e101930. doi: 10.1371/journal.pone.0101930.

17.

Development and validation of a new HPV genotyping assay based on next-generation sequencing.

Yi X, Zou J, Xu J, Liu T, Liu T, Hua S, Xi F, Nie X, Ye L, Luo Y, Xu L, Du H, Wu R, Yang L, Liu R, Yang B, Wang J, Belinson JL.

Am J Clin Pathol. 2014 Jun;141(6):796-804. doi: 10.1309/AJCP9P2KJSXEKCJB.

PMID:
24838323
18.

Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review.

Goodrich SK, Schlegel CR, Wang G, Belinson JL.

Future Oncol. 2014 Mar;10(4):647-54. doi: 10.2217/fon.13.228. Review.

PMID:
24754594
19.

The development and evaluation of a community based model for cervical cancer screening based on self-sampling.

Belinson JL, Wang G, Qu X, Du H, Shen J, Xu J, Zhong L, Yi J, Yi X, Wu R.

Gynecol Oncol. 2014 Mar;132(3):636-42. doi: 10.1016/j.ygyno.2014.01.006.

PMID:
24440471
20.

[Relevant factors to female human papillomavirus infection in city and rural areas of Shenzhen].

Liang LY, Du H, Zhang W, Chen Y, Wu B, Qu XF, Wang C, Yang B, Wu RS, Belinson JL, Wu RF.

Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Aug;34(8):796-9. Chinese.

PMID:
24423766

Supplemental Content

Loading ...
Support Center